GSK
GlaxoSmithKline PLC
50.50$
+0.3%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures per share in GBP.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.96 | 3.91 | 3.58 | 3.83 | 3.93 | 3.92 | 3.63 | 3.89 | 4.17 | 4.22 | 3.75 | 4.14 | 16.35 | |
| 1.11 | 1.17 | 0.96 | 1.03 | 1.18 | 1.23 | 0.94 | 1.05 | 1.10 | 1.30 | 0.92 | 1.12 | 4.46 | |
| 2.86 | 2.74 | 2.62 | 2.80 | 2.75 | 2.68 | 2.70 | 2.83 | 3.07 | 2.92 | 2.82 | 3.02 | 11.89 | |
| 0.77 | 0.99 | 0.70 | 0.72 | 0.72 | 0.98 | 0.71 | 0.98 | 0.82 | 1.15 | 0.83 | 1.71 | 4.53 | |
| 1.12 | 1.30 | 1.01 | 1.20 | 1.86 | 1.28 | 1.00 | 1.04 | 1.09 | 1.29 | 1.04 | 1.08 | 4.53 | |
| 1.91 | 2.46 | 1.90 | 2.00 | 2.66 | 2.35 | 1.63 | 1.85 | 1.80 | 2.18 | 1.70 | 2.79 | 8.51 | |
| 0.95 | 0.28 | 0.72 | 0.80 | 0.09 | 0.34 | 1.07 | 0.98 | 1.26 | 0.74 | 1.13 | 0.24 | 3.38 | |
| 0.09 | 0.13 | 0.08 | 0.08 | 0.08 | 0.07 | 0.08 | 0.09 | 0.08 | 0.09 | 0.08 | 0.09 | 0.34 | |
| 0.87 | 0.18 | 0.66 | 0.73 | 0.03 | 0.27 | 1.02 | 0.92 | 1.20 | 0.47 | 1.05 | 0.17 | 2.91 | |
| 0.13 | -0.01 | 0.13 | 0.09 | 0.00 | 0.03 | 0.16 | 0.12 | 0.15 | 0.11 | 0.15 | -0.10 | 0.32 | |
| 0.71 | 0.17 | 0.51 | 0.57 | -0.03 | 0.20 | 0.79 | 0.70 | 0.98 | 0.31 | 0.85 | 0.21 | 2.37 | |
| 1.24 | 0.56 | 1.01 | 1.12 | 0.57 | 0.54 | 1.50 | 1.57 | 1.64 | 0.93 | 1.36 | 1.39 | 5.35 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.